While M&A activity has slowed in the tail end of the first quarter of 2025, including in healthcare, there have been several noteworthy ...

Sen. Josh Hawley, R-Mo., demanded Tuesday that Congress move to stop insurance companies from owning pharmacy benefit ...

Iowa, suggested Congress could once again move to overhaul PBMs’ controversial business practices after legislators pass ...

In 2023, the Blue Shield of California announced that it was dropping CVS Caremark as its pharmacy benefit manager (PBM) and ...

Even if the order takes effect, it will do nothing to address the root causes of the problem it purports to solve.

CVS Health Corporation CVS and The Cigna Group CI shares trading lower Tuesday. President Donald Trump on Monday signed an ...

The Most Favored Nations directive would allow drugmakers to directly sell their products to patients at a lower cost, ...

President Donald Trump on Monday delivered a blow to the private-sector middlemen who negotiate U.S. drug prices in his ...

The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.

The blow came from the highest levels of government, spooking investors and driving down the stock prices of numerous ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

It could improve access to community pharmacies and lower prices. Or it will limit access to critical drugs and impact payers’ ability to contract for a broad range of services. Industry leaders are ...